| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |